tradingkey.logo
tradingkey.logo
Search

Cencora Inc

COR
Add to Watchlist
282.705USD
+11.425+4.21%
Market hours ETQuotes delayed by 15 min
55.00BMarket Cap
21.55P/E TTM

TradingKey Stock Score of Cencora Inc

Currency: USD Updated: 2026-06-22

Key Insights

Cencora Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 4 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 353.18.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Cencora Inc's Score

Industry at a Glance

Industry Ranking
4 / 203
Overall Ranking
62 / 4577
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

27°C

Very Low
Very High
Neutral

Cencora Inc Highlights

StrengthsRisks
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 321.33B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 22.56% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 28.12%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 28.12%.
Undervalued
The company’s latest PE is 20.68, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 188.32M shares, increasing 0.50% quarter-over-quarter.
Held by Manning & Napier Group, LLC
Star Investor Manning & Napier Group, LLC holds 95.28K shares of this stock.

Analyst Rating

Based on 16 analysts
Buy
Current Rating
353.176
Target Price
+29.93%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

How does TradingKey generate the Stock Score of Cencora Inc?

The TradingKey Stock Score provides a comprehensive assessment of Cencora Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Cencora Inc’s performance and outlook.

How do we generate the financial health score of Cencora Inc?

To generate the financial health score of Cencora Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Cencora Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Cencora Inc.

How do we generate the company valuation score of Cencora Inc?

To generate the company valuation score of Cencora Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Cencora Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Cencora Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Cencora Inc.

How do we generate the earnings forecast score of Cencora Inc?

To calculate the earnings forecast score of Cencora Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Cencora Inc’s future.

How do we generate the price momentum score of Cencora Inc?

When generating the price momentum score for Cencora Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Cencora Inc’s prices. A higher score indicates a more stable short-term price trend for Cencora Inc.

How do we generate the institutional confidence score of Cencora Inc?

To generate the institutional confidence score of Cencora Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Cencora Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Cencora Inc.

How do we generate the risk management score of Cencora Inc?

To assess the risk management score of Cencora Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Cencora Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Cencora Inc.
KeyAI